However, we demonstrate a promising therapeutic strategy targeting GSDMB, which may improve KIRC patient prognosis, provide an understanding of the possible underlying mechanisms of action, and provide new insights into GSDMB as a prognostic marker and potential therapeutic target for cancers. This evidence concerns the gene GSDMB and cancer.